Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
April 2003

Transient, Recurrent, White Matter Lesions in X-linked Charcot-Marie-Tooth Disease With Novel Connexin 32 Mutation

Author Affiliations

From the Department of Neurology, University of Ulm, Ulm, Germany (Drs Hanemann and Sperfeld), and the Department of Human Genetics, Universitätsklinikum, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany (Drs Bergmann, Senderek, and Zerres).


Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003

Arch Neurol. 2003;60(4):605-609. doi:10.1001/archneur.60.4.605

Background  X-linked hereditary demyelianting neuropathies (Charcot-Marie-Tooth Disease [CMTX]) caused by mutations in the connexin 32 (Cx32) gene account for approximately 10% to 20% of all hereditary demyelinating neuropathies. Mild subclinical central nervous system (CNS) involvement has been previously described, and CMTX patients with transient white matter lesions allied to CNS symptoms have very recently been described. This is of potential interest, as Cx32 is widely expressed in both peripheral nerve and the brain.

Patients  We describe a family with hereditary demyelinating neuropathy and transient CNS symptoms. For this study, family members underwent genotyping and detailed clinical, electrophysiological, and magnetic resonance imaging examination.

Results  We present a CMTX family with a novel mutation in the Cx32 gene. Affected family members show, in addition to the classic polyneuropathy, transient and reversible white matter lesions on magnetic resonance imaging scans, correlating similarly transient CNS symptoms.

Conclusion  Patients with CMTX can present with transient CNS symptoms and marked white matter lesions on magnetic resonance imaging scans.

HEREDITARY demyelinating neuropathies (CMT) are among some of the most frequent hereditary neurological disorders. X-linked hereditary Charcot-Marie-Tooth disease (CMTX) is quite common and accounts for approximately 10% to 20% of all hereditary demyelinating neuropathies.1 Moreover, most cases have been linked to mutations in the gap junction protein connexin 32 (Cx32). Two connexons, consisting of each of 6 connexins, form a gap junction between 2 cells, and in Schwann cells, Cx32-containing gap junctions make up autoreflexive radial pathways for small molecules. Although Cx32 is also expressed in the liver, pancreas, oligodendrocytes, and astrocytes, no symptoms correlating with liver or pancreatic disease have as yet been observed in CMTX. Subclinical central nervous system (CNS) involvement, detected by, for example, delayed acoustic evoked potential (AEP) and discrete pyramidal signs, has, however, been described and even used to distinguish CMTX from other hereditary demyelinating CMTs.2,3

We present a family with CMTX, presenting a novel mutation in the Cx32 gene and showing transient and reversible white matter lesions in magnetic resonance imaging (MRI) concomitantly to variable and reversible CNS symptoms.


The family, the pedigree of which is depicted in Figure 1, was recruited from our neuromuscular outpatient clinic.

Figure 1.
Image not available

Family pedigree. Open circles indicate unaffected females; closed circles, affected females; open squares, unaffected males; closed squares, affected males; cross-out symbol, deceased patients. In case III-4, genetic status on examination is, to date, unclear, and clinical and electrophysiological investigations were normal. Double cross-out marks indicate divorce. For patients marked with arrows, genetic testing was performed.


These patients showed no evidence of motor symptoms, foot deformities, or sensory disturbances. Patient II-6 was a newborn girl who died of unknown cause immediately after birth, and another child (III-1) died not long after birth of heart failure.


From age 7 years, this (presently) 43-year-old woman had a slight gait disturbance, discrete foot deformities, and leg cramps. During puberty, she experienced repeated attacks of transient paraparesis or monoparesis. In the course of these events, the degree of paresis varied, having an either slowly or rapidly progressive character and persisting for between a few hours and 2 days at the longest. These symptoms recurred at irregular intervals, mainly following trivial respiratory tract infections throughout a period of 10 years. However, she describes no episode in the 10 years preceding our research. Table 1 presents the clinical and electrophysiological data that were retrieved from the most recent examination. An MRI of the brain at this time showed no abnormalities (data not shown).

Table 1. 
Image not available
Clinical and Electrophysiological Data Retrieved From the Most Recent Examinations

This young male was born prematurely and had bilateral pes cavus at birth. Milestones were delayed. At age 10 years, a sudden flaccid and fluctuating tetraparesis with predominance in the lower limbs occurred after a football training, and receded within an hour. No evidence of an epileptic seizure, loss of consciousness, or behavior disturbances were documented. He was taking no medication, and neither intoxication nor fasting periods were found in the recent past. A second attack occurred several months later — approximately 3 weeks after a stay in a mountain chalet. At onset, the child displayed behavior abnormalities and disorientation for time and place. Later, severe fluctuating dysarthria, motor aphasia, and a transient spastic hemiparesis developed. Symptoms persisted for 3 hours. Magnetic resonance imaging of the brain showed bilateral white matter lesions in the diffusion-weighted sequence, which were not enhanced by gadolinium in T2-weighted images (Figure 2, A and C). In addition, identical abnormalities were found in both cerebellar peduncles (data not shown). An MRI scan of the whole spinal cord showed no abnormalities. Three months later (Figure 2, B and D), these lesions had almost completely vanished. Table 1 presents results of examination at age 12 years. At age 13 years, the patient died of osteosarcoma.

Figure 2.
Image not available

Magnetic resonance images of patient III-2, with diffusion-weighted (A and B) and T2-weighted (C and D) transverse sections. C, Abnormal hyperintensities in parietal white matter were documented. D, Three months later, a virtually complete disappearance of findings was observed.


After the premature birth of this boy, his milestones were reached late. From early infancy through puberty, brief and transient episodes of dysarthria, dysphagia, palsy of one or more cranial nerves, as well as rarer attacks leading to gait disturbances, occurred without any discernible cause, sometimes after infections. An MRI scan during one of such episodes showed diffuse hyperintensities in almost all white matter regions, though without gadolinium enhancement (Figure 3A). Abnormalities were most pronounced in parietal white matter and were also documented in the unilateral cerebellar peduncle. Two months later, these MRI abnormalities were virtually completely gone (Figure 3B). One severe episode occurred at age 19 years 5 weeks, following appendectomy after mononucleosis. The young man then suddenly developed bilateral facial palsy, impaired function of the third cranial nerve, as well as severe dysphagia and dysarthria. These symptoms persisted for an hour and reappeared 24 hours later. At this point, MRI scans of brain and spinal cord were performed. The brain MRI scan showed identical abnormalities to those described above, and no abnormalities were observed in the spinal cord. The MRI (6 months after the last episode) shows discrete hyperintensities in the parietal white matter (Figure 3C). To date, clinical examination data are presented in Table 1.

Figure 3.
Image not available

Magnetic resonance images (MRI) of patient III-3, with T2-weighted transverse sections. A, Nearly all white matter shows diffuse hyperintensities with a predominance in the parietal region. B, Two months later the abnormalities had abated. C, On up-to-date MRI, mild abnormalities in cerebral white matter are documented.

Normal laboratory analysis of all subjects included serum levels of urea, creatinine, creatine kinase, C-reactive protein, homocysteine, serum folate, methylmalionic acid, fasting morning blood glucose, free triiodothyronine, free thyroxine, and thyreotropin; a quantitative estimation of immunoglobuline subclasses G, A, and M serum electrophoresis; anti–Borrelia burgdorferi antibody titer, antinuclear antibodies, ultralong fatty acids,amino acid distribution, liver enzymes, organic acids, phytanic acid, lysosomal enzymes, herpes simplex virus diagnosis, cytomegalovirus diagnosis, varicella zoster virus diagnosis, Epstein-Barr virus diagnosis, measles diagnosis, coxsackievirus diagnosis, human immunodeficiency virus–infection diagnosis, and Treponema pallidum microhemagglutination assay. In patients III-2 and III-3, repeated cerebrospinal fluid analyses were completed. Results were always normal. In patient III-3, fasting cholesterol and triglyceride levels were slightly elevated.

Genomic DNA was extracted from a blood sample of patient III-2 after informed consent had been given. Initially, a PMP22 duplication on chromosome 17p11.2 was excluded with a set of polymorphic microsatellite markers, and absence of a specific junction fragment was ascertained by using polymerase chain reaction (PCR)–based techniques.4 As the family pedigree was compatible with an X-linked–type transmission, molecular diagnosis was accomplished by direct sequencing of the coding region of the Cx32 gene (ABI PRISM 373A Automated Fluorescent DNA Sequencer; Applied Biosystems, Weiterstadt, Germany) and revealed a deletion of a glutamic acid in codon 102 (304_306delGAG); this mutation had not been reported previously. The deletion was shown to segregate with the phenotype in this family with the patient's mother (II-1) being a heterozygous carrier. DNA samples from other family members or members of the nucleus family and 100 apparently unrelated normal controls were also tested under appropriate single-stranded conformational polymorphism conditions and permitted to exclude a possible polymorphism.


We present a family with a CMTX-type polyneuropathy also presenting transient CNS symptoms, carrying a novel mutation in the Cx32 gene. Clinical and electrophysiological examinations showed the typical picture of a slowly progressive demyelinating neuropathy related to Cx32 mutations.3,5 Remarkably, transient non–gadolinium-enhanced white matter abnormalities, correlating with transient clinical neurological deficits, were observed in this family. Symmetry and sparing of U fibers on MRI are compatible with inherited white matter disease. More interestingly, clinical signs included paresis of one or more cranial nerves, indicating brainstem pathology. After 48 hours at most, clinical pathology had regressed in all cases. Follow-up MRI scans showed that the abnormalities observed in T2-weighted sequences were markedly reduced. Irrespective of the transient abnormalities and consistent with small permanent residual MRI findings (Figure 3C), clinical and electrophysiological examination showed mild persistent signs of CNS involvement in our patients.

Cosegregation of 2 different genetic defects, one causing CMTX, the other a white matter disease of the CNS, seems unlikely, as to date, 3 independent reports, including ours, describe the association of CNS symptoms and concomitant transient white matter lesions with CMTX (summarized in Table 2).68 Furthermore, many reports document subclinical involvement of CNS in CMTX (eg, delayed AEP, motor evoked potential, and somatosensory evoked potential).3,9 Also, as Cx32 is expressed in oligodendrocytes, it is conceivable that certain Cx32 mutations might lead to white matter abnormalities and CNS symptoms.

Table 2. 
Image not available
Association of CNS Symptoms With White Matter Lesions in Charcot-Marie-Tooth Disease

Different binding partners and different cellular localization in the CNS and peripheral nervous system (PNS) may be the reason why usually the PNS is predominantly affected in CMTX. Certain Cx32 mutations, like the one described here, may however cause obvious CNS disease. As Cx32 knockout mice have a normal CNS, these Cx32 mutations leading to CNS symptoms may act transdominant negative on other connexins known to be expressed in oligodendrocytes such as Cx47 and Cx27.10 The existence of such transdominant negative effects has been described in vitro.11,12

There is as yet no hotspot for Cx32 mutations associated with CNS symptoms. The described mutations which have been associated with CNS disease are found to correspond to amino acids of the extracellular as well as intracellular or transmembrane regions of the protein. Thus the dominant negative effect is probably either heteromeric or heterotopic.

In analogy to channelopathies, altered gating properties of connexons with mutated Cx32 could theoretically give rise to transient CNS symptoms. Situations of metabolic stress may further alter the function of gap junctions and cause transient symptoms.

Whatever the exact pathomechanism turns out to be, it is important to remember that there are clinical examples, as well as a good theoretical background supporting the idea that the second most frequent hereditary demyelinating neuropathy can not only lead to subclinical CNS involvement, but can cause patent CNS disease.

Back to top
Article Information

Corresponding author: C. Oliver Hanemann, MD, Dept of Neurology, University of Ulm, Steinhövelstr. 1, 89075 Ulm, Germany (e-mail:

Accepted for publication November 19, 2002.

Author contributions: Study concept and design (Dr Hanemann); acquisition of data (Drs Hanemann, Bergmann, Senderek, Zerres, and Sperfeld); analysis and interpretation of data (Dr Hanemann); drafting of the manuscript (Drs Hanemann and Sperfeld); critical revision of the manuscript for important intellectual content (Drs Bergmann, Senderek, and Zerres); administrative, technical, and material support (Drs Hanemann, Zerres, and Sperfeld); study supervision (Dr Hanemann).

We thank Katherine Kämpchen for critical reading of the manuscript.

Hanemann  CO Demyelinating neuropathies: hereditary. Enyclopedia of the Human Genome. London, England: Nature Publishing Group; In press.
Nicholson  GCorbett  A Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain stem auditory evoked responses. J Neurol Neurosurg Psychiatry.1996;61:43-46.
Nicholson  GAYeung  LCorbett  A Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations. Neurology.1998;51:1412-1416.
Stronach  EAClark  CBell  C  et al Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies. J Peripher Nerv Syst.1999;4:117-122.
Birouk  NLeGuern  EMaisonobe  T  et al X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology.1998;50:1074-1082.
Panas  MKaradimas  CAvramopoulos  DVassilopoulos  D Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations. J Neurol Neurosurg Psychiatry.1998;65:947-948.
Panas  MKalfakis  NKaradimas  CVassilopoulos  D Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene. Neurology.2001;57:1906-1908.
Paulson  HLGarbern  JYHoban  TF  et al Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol.2002;52:429-434.
Bahr  MAndres  FTimmerman  VNelis  MEVan Broeckhoven  CDichgans  J Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry.1999;66:202-206.
Scherer  SSXu  YTNelles  EFischbeck  KWillecke  KBone  LJ Connexin32-null mice develop demyelinating peripheral neuropathy. Glia.1998;24:8-20.
Ressot  CBruzzone  R Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev.2000;32:192-202.
Abrams  CKOh  SRi  YBargiello  TA Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev.2000;32:203-214.
Ludin  HP Praktische Elektromyographie.  Stuttgart, Germany: Enke Verlag; 1993.